KPV
(Lysine–Proline–Valine)
Targeted Anti-Inflammatory and Gut-Skin Axis Support
1,000 + Patients Served
24 /7 Telehealth Access
15 + Treatments Available
98 % Patient Satisfaction
Overview
KPV is a naturally derived tripeptide fragment of α-melanocyte-stimulating hormone (α-MSH) with potent anti-inflammatory and immunomodulatory properties. Unlike its parent compound, KPV retains therapeutic signaling effects without pigmentary activity, making it an area of interest in regenerative and wellness medicine.
Potential Clinical Applications
Immune modulation in chronic inflammatory states
Wound healing and tissue repair support
Skin conditions (acne, eczema, inflammatory dermatoses)
Gastrointestinal inflammation support (gut barrier integrity, IBD-type symptoms)
Clinical Rationale
KPV is associated with modulation of key inflammatory pathways:
Immune system regulation and cytokine balance
Inhibition of NF-κB and pro-inflammatory cytokines
Reduction of oxidative stress and inflammatory signaling
Support of epithelial barrier function (gut and skin)
It is positioned as a targeted anti-inflammatory peptide, particularly relevant to chronic inflammatory conditions and barrier dysfunction.
Administration
Oral, topical, or subcutaneous routes depending on clinical goals. Dosing and duration are individualized based on patient-specific goals and clinical context.
Wellness & Regenerative Focus
KPV is often incorporated into protocols targeting the gut-skin axis, inflammation control, and recovery—supporting a more balanced immune response and improved tissue resilience when combined with lifestyle and metabolic optimization.
DISCLAIMER: These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Peptide therapy may carry risks and side effects. Please discuss with your provider to determine if this treatment is right for you.